Sun Pharma secured a firm toehold in the Japanese market after striking a $293 million deal with Novartis AG to acquire 14 of Novartis’ branded drug portfolio program in that country.
Sole issue relates to third-party manufacturing observations: no new clinical studies were requested and no safety or efficacy issues were identified.
InterbrandHealth Report Reveals Top Biopharma Brands: Leaders Are Addressing Needs of Healthcare Professionals to Tackle the Challenges of Today
Pfizer and the Roche Group claim the #1 and #2 positions for leading the way in redefining their value to HCPs March 30, 2016 01:26 AM Eastern Daylight Time NEW YORK–(BUSINESS WIRE)–A global study released today by InterbrandHealth identifies the biopharma companies that are addressing healthcare professionals’ (HCPs), payers’, and policymakers’ needs. A […]
Panchak Named Senior Digital Strategist at FreshBlood’s Consortium of Healthcare Industry Experts.
An advisory panel to the U.S. Food and Drug Administration backed an approval for Acadia Pharmaceuticals Inc’s drug for psychosis related to Parkinson’s disease. Nuplazid’s benefits outweighed the risks, the panel said, after 12 members voted in favor of the treatment and two against. Acadia’s shares, which were halted for trading during market hours on […]
Billionaire Michael Bloomberg and other philanthropists are donating $125 million to Johns Hopkins University for a new institute devoted to immunotherapy cancer research, the Baltimore school said on Tuesday. Bloomberg, founder of the business and market news firm bearing his name and a former New York City mayor, and Sidney Kimmel, founder of Jones Apparel […]
With a nod to his own drug use as a young man, President Barack Obama on Tuesday called for more funding and a new approach to help people addicted to heroin and prescription drugs, seeking to shine a public spotlight on an increasingly deadly killer. During an appearance at a drug abuse summit in Atlanta, […]
Although SXSW 2016 lacked a major platform launch, it did further the tech discussion in key areas.
March 29, 2016 By Alex Keown, BioSpace.com Breaking News Staff CAMBRIDGE, Mass. – Citing a need to invest in growth of its drug products, Ariad Pharmaceuticals (ARIA) slashed 25 percent of employees in the U.S. and Europe, the company announced Tuesday afternoon. Ariad said the job reductions are part of a strategic review aimed […]
DURECT announced its licensee, Pain Therapeutics, has resubmitted the New Drug Application for REMOXY (oxycodone capsules CII) to the U.S. Food and Drug Administration.